Glen Campbell joins BMJ on 2 September. He comes from Elsevier, where he was Executive Vice President for Society Business Development, STM Journals. Glen has spent most of his working life at Elsevier, where up until his most recent role, he worked in its Health Sciences Division. More recently, in his role as EVP for Global Medical Research, Glen was responsible for the worldwide journals programme of Elsevier Health Sciences, overseeing more than 400 titles.
BMJ CEO Tim Brooks commented: “The BMJ board agreed earlier this year that in order to maintain the momentum of our growth outside our home market, it was essential to recruit local senior management in key territories. Glen is a most experienced professional, who brings a lifelong knowledge of medical publishing, and unrivalled contacts in the US health sector. His appointment follows that of Anand Ekambaram to the corresponding role in India, announced last month.”
He added: “For most of its long history, BMJ has been a British business with a pleasing line in exports. However, most of our revenues now originate outside the UK, and the arrival of Glen and Anand signals a transition to a multi-centre, global business.”
Glen commented: “I am thrilled to be joining BMJ to work on the expansion of its US business. With the medical research journal in a period of evolution, The BMJ itself has been a dynamic and creative innovator in both content and business models. BMJ Clinical Evidence and BMJ Best Practice have also broken new ground in providing clinicians with evidence-based information and knowledge. There is boundless opportunity in the US, and I look forward to building on BMJ’s current success in this market to realize its full potential.”
